FDA Withdraws Approval of Prescription Pain Medications with High Acetaminophen Content

Summary

The US Food and Drug Administration (FDA) is correcting a notice that withdrew approval of 108 prescription pain medications containing more than 325 milligrams of acetaminophen per dosage unit, while failing to withdraw approval of three specific applications held by Ranbaxy Laboratories Inc. and Pharmaceutical Associates, Inc.